Active Receptor Tyrosine Protein Kinase erbB-2 (ErbB2)

CD340; EGFR2; HER-2/neu; HER2; NEU; MLN 19; NGL; TKR1; p185; Epidermal Growth Factor Receptor 2; V-Erb-B2 Erythroblastic Leukemia Viral Oncogene Homolog 2; Neuro/Glioblastoma Derived Oncogene Homolog

ACTIVITY TEST

Figure. The binding activity of EGRF2 with ACTb.
The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. Epidermal growth factor receptor 2 (EGFR2) is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. The EGFR is essential for ductal development of the mammary glands, and agonists of the EGFR such as amphiregulin, TGF-α, and heregulin induce both ductal and lobuloalveolar development even in the absence of estrogen and progesterone. Besides, Actin Beta (ACTb) has been identified as an interactor of EGFR2, thus a binding ELISA assay was conducted to detect the interaction of recombinant human EGFR2 and recombinant human ACTb. Briefly, EGFR2 were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100uL were then transferred to ACTb-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-EGFR2 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of EGFR2 and ACTb was shown in Figure 1, and this effect was in a dose dependent manner.

USAGE

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Neuroscience Letter Therapeutic effect of co-transplantation of neuregulin 1-transfected-Schwann cells and bone marrow stromal cells on spinal cord hemisection syndrom Cyagen: source
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB867Hu01 Recombinant Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) Positive Control; Immunogen; SDS-PAGE; WB.
APB867Hu01 Active Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) Cell culture; Activity Assays.
RPB867Hu02 Recombinant Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) Positive Control; Immunogen; SDS-PAGE; WB.
PAB867Hu02 Polyclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC; IP.
PAB867Hu01 Polyclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC; IP.
LAB867Hu81 FITC-Linked Polyclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC; IF.
LAB867Hu71 Biotin-Linked Polyclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC.
MAB867Hu21 Monoclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC; IP.
MAB867Hu22 Monoclonal Antibody to Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) WB; IHC; ICC; IP.
SEB867Hu ELISA Kit for Receptor Tyrosine Protein Kinase erbB-2 (ErbB2) Enzyme-linked immunosorbent assay for Antigen Detection.